Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY: HIMS )

49.28 -17.13 (-25.79%)
Official Closing Price Updated: 7:00 PM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Where Hims & Hers Health Stands With Analysts
Analysts have provided the following ratings for Hims & Hers Health (NYSE:HIMS) within the last quarter: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Upgrades 
Via Benzinga
SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
This Stock Could 10X in 5 Years
An assessment of the company's prospects reveal an ecouraging outlook. 
Via The Motley Fool
4 Analysts Have This to Say About Hims & Hers Health
  Within the last quarter, Hims & Hers Health (NYSE:HIMS) has observed the following analyst ratings: 
Via Benzinga
Hims & Hers Health: Q2 Earnings Insights
  Hims & Hers Health (NYSE:HIMS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. 
Via Benzinga
Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
Gainers 
Via Benzinga
SVB Securities Sees 26% Downside In This Telehealth Platform
Via Benzinga
Hims & Hers Health, Inc. Reports Third Quarter 2022 Financial Results and Raises Full Year 2022 Outlook; Platform Demand and Financial Outperformance Driving Expected Adjusted EBITDA Profitability Beginning in Q4 2022
From Hims & Hers Health, Inc.
Via Business Wire
Earnings Preview For Hims & Hers Health
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers... 
Via Benzinga
Hims & Hers to Announce Third Quarter 2022 Earnings on November 7, 2022
From Hims & Hers Health, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
Upgrades 
Via Benzinga
What 4 Analyst Ratings Have To Say About Hims & Hers Health
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Hims & Hers appoints Chief Communications Officer & VP of Fulfillment Operations
From Hims & Hers Health, Inc.
Via Business Wire
Now More Than Ever Americans Are Open To Exploring Their Sexuality, Hims & Hers’ Nationwide Survey Uncovers The Realities Of Sex In America Today
From Hims & Hers Health, Inc.
Via Business Wire
What 4 Analyst Ratings Have To Say About Hims & Hers Health
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
Hims & Hers Launches New Android Apps
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health's Return on Invested Capital Overview
Benzinga Pro data, Hims & Hers Health (NYSE:HIMS) reported Q2 sales of $113.56 million. Earnings fell to a loss of $19.68 million, resulting in a 21.09% decrease from last quarter. 
Via Benzinga
What Is Going on With Teladoc (TDOC) Stock Today?
With Amazon dropping out of the telehealth business, Teladoc Health moved higher though TDOC stock may struggle longer term. 
Via InvestorPlace
Hims & Hers Health, Inc. Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
Earnings Preview For Hims & Hers Health
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 15, 2022
  
Via Benzinga
Hims & Hers Health, Inc. to Announce Second Quarter 2022 Financial Results and Host Conference Call on August 8, 2022
From Hims & Hers Health, Inc.
Via Business Wire
3 Stocks Under $5 Insiders Are Aggressively Buying
U.S. stocks closed sharply lower, with the Nasdaq Composite dipping around 450 on Thursday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
7 Penny Stocks That Actually Have Analyst Buy Ratings
Many penny stocks (stocks trading for less than $5 per share) have little analyst coverage, but these seven have sell-side "buy" ratings. 
Via InvestorPlace
Hers Doubles Down On Commitment To Women’s Wellness With Launch of 6 New Hers Wellness Essentials Supplements
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Announces 2022 Pride Tour Partnership with Drag Superstars Violet Chachki, Gottmik, and LGBTQ Youth Support Organization, The Trevor Project
From Hims & Hers
Via Business Wire
< Previous 1 2
...
16 17 18 19 20 21 22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.